(Q36862936)

16 August 2017

Response and resistance to BET bromodomain inhibitors in triple-negative breast cancer (English)

1 reference

triple-negative breast cancer

16 August 2017

1 reference

Daniel G Stover

14

Daniel G.

Stover

0 references

Housheng Hansen He

3

Housheng Hansen

He

0 references

Myles Brown

35

Myles

Brown

0 references

29

Richard A. Young

Richard A.

Young

1 reference

16 August 2017

37

Clifford A. Meyer

Clifford A.

Meyer

1 reference

16 August 2017

39

Kornelia Polyak

1 reference

16 August 2017

30

Eric Winer

1 reference

16 August 2017

18

Ian E Krop

1 reference

16 August 2017

Shaokun Shu

1

1 reference

16 August 2017

Charles Y Lin

2

1 reference

16 August 2017

Robert M Witwicki

4

1 reference

16 August 2017

Doris P Tabassum

5

1 reference

16 August 2017

Justin M Roberts

6

1 reference

16 August 2017

Michalina Janiszewska

7

1 reference

16 August 2017

Sung Jin Huh

8

1 reference

16 August 2017

Yi Liang

9

1 reference

16 August 2017

Jeremy Ryan

10

1 reference

16 August 2017

Ernest Doherty

11

1 reference

16 August 2017

Hisham Mohammed

12

1 reference

16 August 2017

Hao Guo

13

1 reference

16 August 2017

Muhammad B Ekram

15

1 reference

16 August 2017

Jonathan Brown

16

1 reference

16 August 2017

Clive D'Santos

17

1 reference

16 August 2017

Deborah Dillon

19

1 reference

16 August 2017

Michael McKeown

20

1 reference

16 August 2017

Christopher Ott

21

1 reference

16 August 2017

Jun Qi

22

1 reference

16 August 2017

Min Ni

23

1 reference

16 August 2017

Prakash K Rao

24

1 reference

16 August 2017

Melissa Duarte

25

1 reference

16 August 2017

Shwu-Yuan Wu

26

1 reference

16 August 2017

Cheng-Ming Chiang

27

1 reference

16 August 2017

Lars Anders

28

1 reference

16 August 2017

Antony Letai

31

1 reference

16 August 2017

William T Barry

32

1 reference

16 August 2017

Jason S Carroll

33

1 reference

16 August 2017

Henry Long

34

1 reference

16 August 2017

X Shirley Liu

36

1 reference

16 August 2017

James E Bradner

38

1 reference

16 August 2017

language of work or name

English

0 references

publication date

6 January 2016

1 reference

16 August 2017

1 reference

16 August 2017

529

1 reference

16 August 2017

7586

1 reference

16 August 2017

413-417

1 reference

describes a project that uses

16 August 2017

ImageJ

1 reference

11 June 2022

https://www.ebi.ac.uk/europepmc/webservices/rest/PMC4854653/fullTextXML

based on heuristic

inferred from PubMed Central ID database lookup

cites work

Transcriptional plasticity promotes primary and acquired resistance to BET inhibition

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4854653

BET inhibitor resistance emerges from leukaemia stem cells

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4854653

PP2A inhibition determines poor outcome and doxorubicin resistance in early breast cancer and its activation shows promising therapeutic effects

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4854653

Drug-induced death signaling strategy rapidly predicts cancer response to chemotherapy.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4854653

Comprehensive genomic analysis identifies novel subtypes and targets of triple-negative breast cancer

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4854653

Outcomes by tumor subtype and treatment pattern in women with small, node-negative breast cancer: a multi-institutional study

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4854653

Phenothiazines induce PP2A-mediated apoptosis in T cell acute lymphoblastic leukemia.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4854653

Genome-wide localization of small molecules

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4854653

Discovery and characterization of super-enhancer-associated dependencies in diffuse large B cell lymphoma.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4854653

Super-enhancers in the control of cell identity and disease

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4854653

HIF-1 mediates metabolic responses to intratumoral hypoxia and oncogenic mutations

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4854653

The CRAPome: a contaminant repository for affinity purification-mass spectrometry data

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4854653

Molecular profiling of human mammary gland links breast cancer risk to a p27(+) cell population with progenitor characteristics.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4854653

BH3 profiling in whole cells by fluorimeter or FACS

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4854653

Selective inhibition of tumor oncogenes by disruption of super-enhancers

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4854653

Master transcription factors and mediator establish super-enhancers at key cell identity genes

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4854653

Targeting MYCN in neuroblastoma by BET bromodomain inhibition

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4854653

Endogenous purification reveals GREB1 as a key estrogen receptor regulatory factor

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4854653

Phospho switch triggers Brd4 chromatin binding and activator recruitment for gene-specific targeting

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4854653

Transcriptional amplification in tumor cells with elevated c-Myc.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4854653

BET domain co-regulators in obesity, inflammation and cancer

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4854653

Dissecting the heterogeneity of triple-negative breast cancer

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4854653

BET bromodomain inhibition as a therapeutic strategy to target c-Myc

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4854653

Identification of human triple-negative breast cancer subtypes and preclinical models for selection of targeted therapies

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4854653

The JAK2/STAT3 signaling pathway is required for growth of CD44⁺CD24⁻ stem cell-like breast cancer cells in human tumors

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4854653

Selective inhibition of BET bromodomains

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4854653

Transcript assembly and quantification by RNA-Seq reveals unannotated transcripts and isoform switching during cell differentiation

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4854653

TopHat: discovering splice junctions with RNA-Seq

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4854653

Ultrafast and memory-efficient alignment of short DNA sequences to the human genome

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4854653

Model-based analysis of ChIP-Seq (MACS)

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4854653

Protein phosphatase 2A regulatory subunits and cancer.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4854653

Multiple pathways regulated by the tumor suppressor PP2A in transformation

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4854653

Quantitative analysis of dose-effect relationships: the combined effects of multiple drugs or enzyme inhibitors

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4854653

NF-κB directs dynamic super enhancer formation in inflammation and atherogenesis

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4854653

Functional Synergies yet Distinct Modulators Affected by Genetic Alterations in Common Human Cancers

27 June 2018

1 reference

Crossref

https://api.crossref.org/works/10.1038%2FNATURE16508

The OCT4 pseudogene POU5F1B is amplified and promotes an aggressive phenotype in gastric cancer

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/26735014

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1038/NATURE16508

1 reference

16 August 2017

1 reference

16 August 2017

PubMed publication ID

26735014

1 reference